RIPK2 Antikörper (AA 1-540) (FITC)

Produktnummer ABIN7348251

Produktdetails anti-RIPK2 Antikörper (FITC)

Target: RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

Bindungsspezifität: AA 1-540

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RIPK2 Antikörper ist konjugiert mit FITC

Applikation: Bitte anfragen

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Receptor-interacting serine/threonine-protein kinase 2 protein (1-540AA)

Isotyp: IgG

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu RIPK2

Target: RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

Andere Bezeichnung: RIPK2 (RIPK2 Produkte)

Synonyme: RIPK2 antikoerper, 2210420D18Rik antikoerper, CARD3 antikoerper, CARDIAK antikoerper, CCK antikoerper, D4Bwg0615e antikoerper, RICK antikoerper, RIP2 antikoerper, GIG30 antikoerper, receptor interacting serine/threonine kinase 2 antikoerper, receptor (TNFRSF)-interacting serine-threonine kinase 2 antikoerper, receptor-interacting serine-threonine kinase 2 antikoerper, RIPK2 antikoerper, Ripk2 antikoerper

Hintergrund:

Background: Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Once recruited, RIPK2 autophosphorylates and undergoes \\\'Lys-63\\\'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3. The polyubiquitinated protein mediates the recruitment of MAP3K7/TAK1 to IKBKG/NEMO and induces \\\'Lys-63\\\'-linked polyubiquitination of IKBKG/NEMO and subsequent activation of IKBKB/IKKB. In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Plays also a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation.

Aliases: CARD 3 antibody, CARD carrying kinase antibody, CARD containing ICE associated kinase antibody, CARD containing IL 1 beta ICE kinase antibody, CARD containing IL1 beta ICE kinase antibody, CARD containing interleukin 1 beta converting enzyme (ICE) associated kinase antibody, CARD containing interleukin 1 beta converting enzyme associated kinase antibody, CARD-containing IL-1 beta ICE-kinase antibody, CARD-containing interleukin-1 beta-converting enzyme-associated kinase antibody, CARD3 antibody, CARDIAK antibody, CCK antibody, CLARP kinase antibody, GIG 30 antibody, GIG30 antibody, Growth inhibiting gene 30 antibody, Receptor interacting protein (RIP) like interacting caspase like apoptosis regulatory protein (CLARP) kinase antibody, Receptor interacting protein 2 antibody, Receptor interacting serine threonine kinase 2 antibody, Receptor interacting serine/threonine protein kinase 2 antibody, Receptor-interacting protein 2 antibody, Receptor-interacting serine/threonine-protein kinase 2 antibody, RICK antibody, RIP 2 antibody, RIP like interacting CLARP kinase antibody, RIP-2 antibody, RIP-like-interacting CLARP kinase antibody, RIPK 2 antibody, Ripk2 antibody, RIPK2_HUMAN antibody, TNFRSF antibody, Tyrosine-protein kinase RIPK2 antibody, UNQ277/PRO314/PRO34092 antibody

UniProt: O43353

Pathways: T-Zell Rezeptor Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades